Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects

Abroad (travel likely)RecruitingPHASE2

Conditions

Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Innovacion y Desarrollo de Estrategias en Salud, Mexico City, Mexico
Contact: Study coordinator (Cesar D Nieto Rufino, MD, MSc) · cesar.nieto@ideas-salud.mx · +525554564480
Contact: Study coordinator (Paola Juarez Valdez, MD) · paola.juarez@ideas-salud.mx · +525528950479
Contact: Principal Investigator (Veronica Narvaez Rosales, MD)

Study leads

Veronica Narvaez Rosales, MD
Principal Investigator
Innovacion y Desarrollo de Estrategias en Salud

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Atopic Dermatitis (AD) · Psoriasis (PsO)

Abroad (travel likely)RecruitingPHASE1

Fargo, United States · Dallas, United States

A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis · Moderate to Severe Plaque Psoriasis

Abroad (travel likely)Recruiting

Shanghai, China